TPI [TIANYIN PHARMACEUTICAL] NT 10-K: (Original Filing)
[]
WX [WuXi PharmaTech (Cayman)] CORRESP: (Original Filing)
[787 Seventh Avenue New York, NY 10019-6099 Tel: 212 728 8000 Fax: 212 728 8111 VIA EDGAR September 23, 2015 100 F Street, N.E. Attn: David L. Orlic, Special Counsel Office of Mergers and Acquisitions Re: WuXi PharmaTech (Cayman) Inc. Schedule 13E-3 By WuXi PharmaTech (Cayman) Inc., New WuXi Life Science Holdings Limited, New WuXi Life Science Limited, WuXi Merger]
WX [WuXi PharmaTech (Cayman)] SC 13E3/A: (Original Filing)
[PRELIMINARY PROXY STATEMENT OF THE COMPANY [ ], 2015 Shareholders of WuXi PharmaTech (Cayman) Inc. Re: Notice of Extraordinary General Meeting of Shareholders Dear Shareholder: You are cordially invited to attend an extraordinary general meeting of shareholders of WuXi PharmaTech (Cayman) Inc., an exempted company with limited liability incorporated under the laws of the Cayman Islands (the Company), to be] []
SVA [SINOVAC BIOTECH] 6-K: (Original Filing)
[Sinovac to Participate in Morgan Stanley Global Healthcare Conference BEIJING, September 10, 2015 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate the Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt Hotel in New York City from Wednesday September 16 to Friday September 18,] [Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing BEIJING, September 14, 2015 -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it has been selected by the Beijing government to be a supplier of the seasonal influenza vaccine for its 2015 vaccination campaign. The Beijing government plans to order a] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. 6-K 1 v420222_6k.htm FORM 6-K]
SVA [SINOVAC BIOTECH] 6-K: Sinovac to Participate in Morgan Stanley Global Healthcare
[Sinovac to Participate in Morgan Stanley Global Healthcare Conference BEIJING, September 10, 2015 -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate the Morgan Stanley Global Healthcare Conference, to be held at the Grand Hyatt Hotel in New York City from Wednesday September 16 to Friday September 18,] [Sinovac Receives Tender to Supply Seasonal Flu Vaccine in Beijing BEIJING, September 14, 2015 -- Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today announced that it has been selected by the Beijing government to be a supplier of the seasonal influenza vaccine for its 2015 vaccination campaign. The Beijing government plans to order a] [FORM 6-K -------------- ---------- SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China X Form 20-F ___ SINOVAC BIOTECH LTD. 6-K 1 v420222_6k.htm FORM 6-K]
